| [1] |
Zhao DY, Guo YP, Wei HF, et al. Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets[J]. JCI Insight, 2024, 9(10): e171916. doi:10.1172/jci.insight.171916
|
| [2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-49. doi:10.3322/caac.21660
|
| [3] |
Guo HY, Shu JH, Hu GB, et al. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization[J]. PLoS One, 2024, 19(5): e0302780. doi:10.1371/journal.pone.0302780
|
| [4] |
Wang LJ, Wang XJ, Yan PW, et al. LINC00261 suppresses cisplatin resistance of esophageal squamous cell carcinoma through miR-545-3p/MT1M axis[J]. Front Cell Dev Biol, 2021, 9: 687788. doi:10.3389/fcell.2021.687788
|
| [5] |
Liu XJ, Zhao SM, Wang KK, et al. Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer[J]. Nat Commun, 2023, 14(1): 4779. doi:10.1038/s41467-023-40343-5
|
| [6] |
Yang ZL, Tian H, Chen XW, et al. Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma[J]. Nat Commun, 2024, 15(1): 9097. doi:10.1038/s41467-024-52977-0
|
| [7] |
Xia T, Meng L, Xu GX, et al. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth[J]. Cell Death Dis, 2024, 15(10): 740. doi:10.1038/s41419-024-07137-z
|
| [8] |
Zhou LT, Yao N, Yang L, et al. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β[J]. Cell Rep, 2023, 42(5): 112445. doi:10.1016/j.celrep.2023.112445
|
| [9] |
Chen DY, Chen TY, Guo YX, et al. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo[J]. Exp Cell Res, 2020, 396(1): 112281. doi:10.1016/j.yexcr.2020.112281
|
| [10] |
Yan QH, Wong W, Gong L, et al. Roles of long non-coding RNAs in esophageal cell squamous carcinoma (Review)[J]. Int J Mol Med, 2024, 54(2): 72. doi:10.3892/ijmm.2024.5396
|
| [11] |
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm[J]. Cancer Res, 2017, 77(15): 3965-81. doi:10.1158/0008-5472.can-16-2634
|
| [12] |
Smolarz B, Zadrożna-Nowak A, Romanowicz H. The role of lncRNA in the development of tumors, including breast cancer[J]. Int J Mol Sci, 2021, 22(16): 8427. doi:10.3390/ijms22168427
|
| [13] |
Dai ZT, Wu YL, Xu T, et al. The role of lncRNA SNHG14 in gastric cancer: enhancing tumor cell proliferation and migration, and mechanisms of CDH2 expression[J]. Cell Cycle, 2023, 22(23/24): 2522-37. doi:10.1080/15384101.2023.2289745
|
| [14] |
Mehmandar-Oskuie A, Jahankhani K, Rostamlou A, et al. Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies[J]. Biomed Pharmacother, 2023, 165: 115242. doi:10.1016/j.biopha.2023.115242
|
| [15] |
Liu JQ, Deng M, Xue NN, et al. lncRNA KLF3-AS1 suppresses cell migration and invasion in ESCC by impairing miR-185-5p-targeted KLF3 inhibition[J]. Mol Ther Nucleic Acids, 2020, 20: 231-41. doi:10.1016/j.omtn.2020.01.020
|
| [16] |
Tao QY, Li XJ, Xia YY, et al. LINC00261 triggers DNA damage via the miR-23a-3p/CELF2 axis to mitigate the malignant characteristics of 131I-resistant papillary thyroid carcinoma cells[J]. Biochem Biophys Rep, 2024, 40: 101858. doi:10.1016/j.bbrep.2024.101858
|
| [17] |
Li XY, Li JY, Lu P, et al. LINC00261 relieves the progression of sepsis-induced acute kidney injury by inhibiting NF-κB activation through targeting the miR-654-5p/SOCS3 axis[J]. J Bioenerg Biomembr, 2021, 53(2): 129-37. doi:10.1007/s10863-021-09874-8
|
| [18] |
Fang QJ, Sang L, Du SH. Long noncoding RNA LINC00261 regulates endometrial carcinoma progression by modulating miRNA/FOXO1 expression[J]. Cell Biochem Funct, 2018, 36(6): 323-30. doi:10.1002/cbf.3352
|
| [19] |
Li Y, Wu CH. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells[J]. IUBMB Life, 2021, 73(1): 188-201. doi:10.1002/iub.2416
|
| [20] |
Zou J, Pei XZ, Xing D, et al. LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3[J]. J Cell Mol Med, 2021, 25(20): 9826-36. doi:10.1111/jcmm.16930
|
| [21] |
Liao J, Dong LP. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition[J]. Eur Rev Med Pharmacol Sci, 2019, 23(9): 3829-37.
|
| [22] |
Lin WY, Zhou QY, Wang CQ, et al. LncRNAs regulate metabolism in cancer[J]. Int J Biol Sci, 2020, 16(7): 1194-206. doi:10.7150/ijbs.40769
|
| [23] |
Xue ST, Zheng B, Cao SQ, et al. Long non-coding RNA LINC00680 functions as a CeRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis[J]. Mol Cancer, 2022, 21(1): 69. doi:10.1186/s12943-022-01539-3
|
| [24] |
Han G, Guo QY, Ma N, et al. Apatinib inhibits cell proliferation and migration of osteosarcoma via activating LINC00261/miR-620/PTEN axis[J]. Cell Cycle, 2021, 20(18): 1785-98. doi:10.1080/15384101.2021.1949132
|
| [25] |
Yan DS, Liu WD, Liu YL, et al. LINC00261 suppresses human colon cancer progression via sponging miR-324-3p and inactivating the Wnt/β‑catenin pathway[J]. J Cell Physiol, 2019, 234(12): 22648-56. doi:10.1002/jcp.28831
|
| [26] |
Zuo H, Liu S, Li X, et al. miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4[J]. Clin Transl Oncol, 2023, 25(4): 933-40. doi:10.1007/s12094-022-02996-4
|
| [27] |
Lu YJ, Chan YT, Tan HY, et al. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2022, 41(1): 3. doi:10.1186/s13046-021-02208-x
|
| [28] |
Ma Y, Gao JB, Guo HN. miR-23a-3p regulates Runx2 to inhibit the proliferation and metastasis of oral squamous cell carcinoma[J]. J Oncol, 2022, 2022: 8719542. doi:10.1155/2022/8719542
|
| [29] |
Lee JH, Song SY, Kim MS, et al. Frameshift mutations of a tumor suppressor gene ZNF292 in gastric and colorectal cancers with high microsatellite instability[J]. APMIS, 2016, 124(7): 556-60. doi:10.1111/apm.12545
|
| [30] |
Gong W, Xu J, Wang G, et al. ZNF292 suppresses proliferation of ESCC cells through ZNF292/SKP2/P27 signaling axis[J]. Chin J Cancer Res, 2021, 33(6): 637-48. doi:10.21147/j.issn.1000-9604.2021.06.01
|
| [31] |
Wang X, Gao XZ, Tian JX, et al. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p[J]. Arch Biochem Biophys, 2020, 689: 108469. doi:10.1016/j.abb.2020.108469
|
| [32] |
Lin K, Jiang H, Zhuang SS, et al. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer[J]. FASEB J, 2019, 33(2): 1972-88. doi:10.1096/fj.201800759r
|